Delivery Order SPE2DB22D3501-SPE2DB24FUU11

Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,813.61, is for the delivery of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,863.89 firm fixed-price delivery order is for the supply of 4,564,603,718 units of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has a completion date of May 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,316.57, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,971.52 firm-fixed-price delivery order is for the supply of 4,566,948,280 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,626.35, is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 per package. The contract is a Firm Fixed Price Delivery Order with a completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of 4,566,718,302 units of the drug Ondansetron ODT 4 mg tablets in 30-count packages. The $10,031.45 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,602.89, is for the delivery of 4,561,059,478 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,787.18, is for the delivery of 4,566,947,023 units of Ondansetron HCL 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,790,985 units of Ondansetron ODT 4 mg tablets, with a ceiling value of $7,122.40. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUU11
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,255.16, is a delivery order for 4,563,830,285 units of the medication Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of March 4, 2024 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 9:52 AM